Cutaneous Squamous Cell Carcinoma (CSCC)

Oncology·MeSH: Skin Neoplasms

5 drugs in development·2 companies·4 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
unloxcyt	Fortress Biotech Inc. (FBIO)

Phase 3(3)

Drug	Company
cemiplimab+fianlimab fixed dose combination	REGENERON PHARMACEUTICALS, INC. (REGN)
fdc fianlimab+cemiplimab	REGENERON PHARMACEUTICALS, INC. (REGN)
regn15505+cemiplimab	REGENERON PHARMACEUTICALS, INC. (REGN)

Phase 1(1)

Drug	Company
cemiplimab	REGENERON PHARMACEUTICALS, INC. (REGN)

BioSniper tracks 5 drugs in development for Cutaneous Squamous Cell Carcinoma (CSCC) across 2 companies.

There are 4 clinical trials targeting Cutaneous Squamous Cell Carcinoma (CSCC) tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.